Some people misread this as permission to dose every three days if they want
Sattar, N., McMurray, J
Shabanpour, Y., Hajipour-Verdom, B., Abdolmaleki, P
The primary concerns with using discoloured tirzepatide include: Loss of therapeutic effect : Degradation of the active peptide may render the medication ineffective, leading to inadequate glycaemic control or failure to achieve intended weight management outcomes Potential toxicity : Degradation products or contaminants responsible for the colour change may pose direct health risks Immunogenicity : Altered protein structures can potentially trigger unwanted immune responses Infection risk : If discolouration results from contamination, injection could introduce harmful substances into subcutaneous tissue If you discover discoloured tirzepatide, you should: If you have inadvertently used discoloured tirzepatide and experience symptoms of a severe allergic reaction (such as difficulty breathing, swelling of face/throat, or severe rash), call 999 or go to A&E immediately

Methods We used a combination of glucagon secretion measurements in mouse and human islets (including islets from donors with type 2 diabetes), total internal reflection fluorescence microscopy imaging of secretory granule dynamics, recordings of cytoplasmic Ca 2+ and measurements of protein kinase A activity, immunocytochemistry, in vivo physiology and GTP-binding protein dissociation studies to explore how GLP-1 exerts its inhibitory effect on glucagon secretion and the role of the metabolite GLP-1(936)